CERT
Price
$11.73Alerts
Change
-$0.39 (-3.22%)
Updated
Nov 11 closing price
Capitalization
1.84B
112 days until earnings call
Intraday BUY SELL Signals
OPRX
Price
$8.95Alerts
Change
-$0.40 (-4.28%)
Updated
Nov 11 closing price
Capitalization
165M
105 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CERT vs OPRX

CERT vs OPRX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CERT vs. OPRX commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CERT is a Buy and OPRX is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CERT with price predictions
Nov 11, 2026

CERT in downward trend: price expected to drop as it breaks its higher Bollinger Band on November 05, 2026

CERT broke above its upper Bollinger Band on November 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 33 similar instances where the stock broke above the upper band. In 28 of the 33 cases the stock fell afterwards. This puts the odds of success at 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for CERT moved out of overbought territory on November 11, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 23 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 82%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CERT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on CERT as a result. In 68 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.

The Moving Average Convergence Divergence (MACD) for CERT just turned positive on October 20, 2026. Looking at past instances where CERT's MACD turned positive, the stock continued to rise in 38 of 44 cases over the following month. The odds of a continued upward trend are 86%.

Following a +12.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where CERT advanced for three days, in 234 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

The Aroon Indicator entered an Uptrend today. In 96 of 121 cases where CERT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.902) is normal, around the industry mean (4.477). CERT has a moderately low P/E Ratio (-27.386) as compared to the industry average of (13.414). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (3.051) is also within normal values, averaging (6.065).

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. CERT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CERT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.

A.I.Advisor
a Summary for OPRX with price predictions
Nov 11, 2026

OPRX sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for OPRX moved above the 200-day moving average on October 07, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +9.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where OPRX advanced for three days, in 196 of 261 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

The Aroon Indicator entered an Uptrend today. In 106 of 125 cases where OPRX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.

Bearish Trend Analysis

The 10-day RSI Indicator for OPRX moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In 18 of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at 82%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 49 of 60 cases where OPRX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 82%.

The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OPRX as a result. In 76 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.

The Moving Average Convergence Divergence Histogram (MACD) for OPRX turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 37 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OPRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

OPRX broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. OPRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.259) is normal, around the industry mean (4.477). P/E Ratio (33.692) is within average values for comparable stocks, (13.414). Projected Growth (PEG Ratio) (1.608) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.463) is also within normal values, averaging (6.065).

The Tickeron SMR rating for this company is 86 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OPRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.

FUNDAMENTALS RATINGS
CERT vs OPRX: Fundamental Ratings
CERT
OPRX
OUTLOOK RATING
1..100
8321
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
83
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9386
PRICE GROWTH RATING
1..100
3438
P/E GROWTH RATING
1..100
9897
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CERT's Valuation (13) in the null industry is significantly better than the same rating for OPRX (83) in the Data Processing Services industry. This means that CERT’s stock grew significantly faster than OPRX’s over the last 12 months.

CERT's Profit vs Risk Rating (100) in the null industry is in the same range as OPRX (100) in the Data Processing Services industry. This means that CERT’s stock grew similarly to OPRX’s over the last 12 months.

OPRX's SMR Rating (86) in the Data Processing Services industry is in the same range as CERT (93) in the null industry. This means that OPRX’s stock grew similarly to CERT’s over the last 12 months.

CERT's Price Growth Rating (34) in the null industry is in the same range as OPRX (38) in the Data Processing Services industry. This means that CERT’s stock grew similarly to OPRX’s over the last 12 months.

OPRX's P/E Growth Rating (97) in the Data Processing Services industry is in the same range as CERT (98) in the null industry. This means that OPRX’s stock grew similarly to CERT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CERTOPRX
RSI
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 3 days ago
75%
Declines
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
85%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (CERT: $11.73 vs. OPRX: $8.95)
Brand notoriety: CERT and OPRX are both not notable
Both companies represent the Services to the Health Industry industry
Current volume relative to the 65-day Moving Average: CERT: 127% vs. OPRX: 278%
Market capitalization -- CERT: $1.84B vs. OPRX: $165M
CERT [@Services to the Health Industry] is valued at $1.84B. OPRX’s [@Services to the Health Industry] market capitalization is $165M. The market cap for tickers in the [@Services to the Health Industry] industry ranges from $708 to $49.18B. The average market capitalization across the [@Services to the Health Industry] industry is $3.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CERT’s FA Score shows that 1 FA rating(s) are green while OPRX’s FA Score has 0 green FA rating(s).

  • CERT’s FA Score: 1 green, 4 red.
  • OPRX’s FA Score: 0 green, 5 red.
According to our system of comparison, CERT is a better buy in the long-term than OPRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CERT’s TA Score shows that 4 TA indicator(s) are bullish while OPRX’s TA Score has 3 bullish TA indicator(s).

  • CERT’s TA Score: 4 bullish, 4 bearish.
  • OPRX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CERT is a better buy in the short-term than OPRX.

Price Growth

CERT (@Services to the Health Industry) experienced а +5.77% price change this week, while OPRX (@Services to the Health Industry) price change was -8.86% for the same time period.

The average weekly price growth across all stocks in the @Services to the Health Industry industry was +0.38%. For the same industry, the average monthly price growth was +2.22%, and the average quarterly price growth was +27.51%.

Reported Earning Dates

CERT is expected to report earnings on Mar 04, 2027.

OPRX is expected to report earnings on Feb 25, 2027.

Industries' Descriptions

@Services to the Health Industry (+0.38% weekly)

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

View a ticker or compare two or three
Interact to see
Advertisement

CERT and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERT has been loosely correlated with SLP. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CERT jumps, then SLP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERT
1D Price
Change %
CERT100%
-3.26%
SLP - CERT
51%
Loosely correlated
N/A
SDGR - CERT
44%
Loosely correlated
-2.75%
COIN - CERT
40%
Loosely correlated
+3.13%
RIOT - CERT
39%
Loosely correlated
+1.11%
PATH - CERT
38%
Loosely correlated
+2.42%
More

OPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, OPRX has been loosely correlated with DOCS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if OPRX jumps, then DOCS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPRX
1D Price
Change %
OPRX100%
-4.28%
DOCS - OPRX
42%
Loosely correlated
+2.47%
CERT - OPRX
41%
Loosely correlated
-3.26%
CXM - OPRX
38%
Loosely correlated
+1.84%
COIN - OPRX
37%
Loosely correlated
+3.13%
RIOT - OPRX
36%
Loosely correlated
+1.11%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AVSC72.060.41
+0.57%
Avantis U.S Small Cap Equity ETF (AVSC)
DBE35.110.12
+0.34%
Invesco DB Energy Fund (DBE)
EFAX53.920.14
+0.26%
State Street SPDR MSCI EAFE Fossil Fuel Reserves Free ETF (EFAX)
AALG18.02N/A
N/A
Leverage Shares 2X Long Aal Daily ETF
FBDC17.01-0.06
-0.35%
FT Confluence BDC & Specialty Finance Income ETF (FBDC)